uploads///Part

David Einhorn Was Right about Apple

By

Nov. 20 2020, Updated 11:02 a.m. ET

David Einhorn’s top sells

After analyzing billionaire investor David Einhorn’s largest holdings, we’ll discuss his top sells in the third quarter, which he discussed in his letter to shareholders.

According to Reuters, Einhorn informed investors that he sold out of drugmakers like Bayer (BAYRY), Mylan (MYL), and Perrigo (PRGO) last year.

Article continues below advertisement

Einhorn’s bet on Apple turned out well

Another key exit for the fund in 2018 was Apple (AAPL). Greenlight Capital (GLRE) exited its position in Apple in the third quarter of 2018. The fund first bought a stake in Apple in 2010 and increased its position in the stock eventually. In his Q3 2018 letter to shareholders, Einhorn said he sold off the remaining Apple stake due to its heightened valuation and growing fear of retaliation in response to US tariffs. As reported by CNBC, he added, “We are somewhat worried about Chinese retaliation against America’s trade policies.”

While many of Greenlight’s bets in 2018 didn’t turn out well, Apple surely was not one of them. Between Greenlight’s exit from Apple on August 31, 2018, and the end of 2018, the stock fell 31%. Einhorn’s decision to exit Apple is in stark contrast to Berkshire Hathaway’s (BRK-B) Warren Buffett’s decision to continue to increase his stake in the stock.

Covering shorts

In addition to exiting his long positions in some stocks, Einhorn also covered some of his short positions in 2018 including Core Laboratories (CLB) and oil frackers. The fund manager, however, remains short Tesla (TSLA). We’ll discuss this in detail in the next part of this series.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.